Macrophage–tumour cell interactions: identification of MUC1 on breast cancer cells as a potential counter‐receptor for the macrophage‐restricted receptor, sialoadhesin

In many carcinomas, infiltrating macrophages are commonly found closely associated with tumour cells but little is known concerning the nature or significance of adhesion molecules involved in these cellular interactions. Here we demonstrate in primary human breast cancers that sialoadhesin (Sn), a macrophage‐restricted adhesion molecule, is frequently expressed on infiltrating cells that often make close contact with breast carcinoma cells. To determine whether Sn could act as a specific receptor for ligands on breast cancer cell lines, binding assays were performed with a recombinant form of the protein fused to the Fc portion of human immunoglobulin G1 (IgG1) (Sn‐Fc). Sn‐Fc was found to bind specifically and in a sialic acid‐dependent manner to the breast cancer cell lines MCF‐7, T47.D and BT‐20 both in solid‐ and solution‐phase binding assays. To investigate the nature of the sialoglycoproteins recognized by Sn on breast cancer cells, MCF‐7 cells were labelled with [6‐3H]glucosamine. Following precipitation with Sn‐Fc, a major band of ≈240 000 MW was revealed, which was shown in reprecipitation and Western blotting experiments to be the epithelial mucin, MUC1.

[1]  J A Sherratt,et al.  Pattern formation and spatiotemporal irregularity in a model for macrophage-tumour interactions. , 1997, Journal of theoretical biology.

[2]  P. Crocker,et al.  The species‐specific structure of microanatomical compartments in the human spleen: strongly sialoadhesin‐positive macrophages occur in the perifollicular zone, but not in the marginal zone , 1997, Immunology.

[3]  H. Stein,et al.  Carbohydrate Recognition on MUC1‐Expressing Targets Enhances Cytotoxicity of a T Cell Subpopulation , 1997, Scandinavian journal of immunology.

[4]  M. Griswold,et al.  Role of E Box and Initiator Region in the Expression of the Rat Follicle-stimulating Hormone Receptor* , 1996, The Journal of Biological Chemistry.

[5]  A. Harris,et al.  Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. , 1996, Cancer research.

[6]  P. Crocker,et al.  Carbohydrate recognition systems: functional triads in cell-cell interactions. , 1996, Current opinion in structural biology.

[7]  L. Pilarski,et al.  The breast mucin MUCI as a novel adhesion ligand for endothelial intercellular adhesion molecule 1 in breast cancer. , 1996, Cancer research.

[8]  J. Wesseling,et al.  A mechanism for inhibition of E-cadherin-mediated cell-cell adhesion by the membrane-associated mucin episialin/MUC1. , 1996, Molecular biology of the cell.

[9]  R. Cummings,et al.  Visualization of P-selectin Glycoprotein Ligand-1 as a Highly Extended Molecule and Mapping of Protein Epitopes for Monoclonal Antibodies (*) , 1996, The Journal of Biological Chemistry.

[10]  J. Peter-Katalinic,et al.  MUC1 Glycoforms in Breast Cancer , 1996 .

[11]  A. Krüger,et al.  A role for sialoadhesin-positive tissue macrophages in host resistance to lymphoma metastasis in vivo. , 1996, Immunology.

[12]  J. Peter-Katalinic,et al.  MUC1 glycoforms in breast cancer--cell line T47D as a model for carcinoma-associated alterations of 0-glycosylation. , 1996, European journal of biochemistry.

[13]  P. A. van der Merwe,et al.  The Amino-terminal Immunoglobulin-like Domain of Sialoadhesin Contains the Sialic Acid Binding Site , 1995, The Journal of Biological Chemistry.

[14]  I. Brockhausen,et al.  Mechanisms underlying aberrant glycosylation of MUC1 mucin in breast cancer cells. , 1995, European journal of biochemistry.

[15]  M. Donowitz,et al.  Separate C-terminal Domains of the Epithelial Specific Brush Border Na+/H+ Exchanger Isoform NHE3 Are Involved in Stimulation and Inhibition by Protein Kinases/Growth Factors (*) , 1995, The Journal of Biological Chemistry.

[16]  J O McGee,et al.  Cytokine regulation of angiogenesis in breast cancer: the role of tumor‐associated macrophages , 1995, Journal of leukocyte biology.

[17]  S. Gordon,et al.  Sialoadhesin binds preferentially to cells of the granulocytic lineage. , 1995, The Journal of clinical investigation.

[18]  M. Filbin,et al.  Sialoadhesin, myelin-associated glycoprotein and CD22 define a new family of sialic acid-dependent adhesion molecules of the immunoglobulin superfamily , 1994, Current Biology.

[19]  S. Gordon,et al.  Sialoadhesin, a macrophage sialic acid binding receptor for haemopoietic cells with 17 immunoglobulin‐like domains. , 1994, The EMBO journal.

[20]  C. Lewis,et al.  Tumour‐associated leucocytes: Friends or foes in breast carcinoma , 1994, The Journal of pathology.

[21]  A. Harris,et al.  Secretion of epidermal growth factor by macrophages associated with breast carcinoma , 1993, The Lancet.

[22]  C. Melief,et al.  Episialin (MUC1) inhibits cytotoxic lymphocyte-target cell interaction. , 1993, Journal of immunology.

[23]  T. K. van den Berg,et al.  Sialoadhesin on macrophages: its identification as a lymphocyte adhesion molecule , 1992, The Journal of experimental medicine.

[24]  J. Taylor‐Papadimitriou,et al.  Antibodies to the cytoplasmic domain of the MUC1 mucin show conservation throughout mammals. , 1992, Biochemical and biophysical research communications.

[25]  J. Taylor‐Papadimitriou,et al.  The product of the human MUC1 gene when secreted by mouse cells transfected with the full-length cDNA lacks the cytoplasmic tail. , 1992, Biochemical and biophysical research communications.

[26]  M. Ligtenberg,et al.  Suppression of cellular aggregation by high levels of episialin. , 1992, Cancer research.

[27]  A. Mantovani,et al.  The origin and function of tumor-associated macrophages. , 1992, Immunology today.

[28]  D. Shotton,et al.  Purification and properties of sialoadhesin, a sialic acid‐binding receptor of murine tissue macrophages. , 1991, The EMBO journal.

[29]  R. Bast,et al.  Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells. , 1991, Cancer research.

[30]  S. Gordon,et al.  Expression of a divalent cation-dependent erythroblast adhesion receptor by stromal macrophages from murine bone marrow. , 1991, Journal of cell science.

[31]  D. Shotton,et al.  The dimensions of the T lymphocyte glycoprotein leukosialin and identification of linear protein epitopes that can be modified by glycosylation. , 1991, The EMBO journal.

[32]  Z. Werb,et al.  Ultrastructural localization of a macrophage-restricted sialic acid binding hemagglutinin, SER, in macrophage-hematopoietic cell clusters. , 1990, Blood.

[33]  J. Taylor‐Papadimitriou,et al.  A short sequence, within the amino acid tandem repeat of a cancer‐associated mucin, contains immunodominant epitopes , 1989, International journal of cancer.

[34]  J. Bártková,et al.  A core protein epitope of the polymorphic epithelial mucin detected by the monoclonal antibody SM‐3 is selectively exposed in a range of primary carcinomas , 1989, International journal of cancer.

[35]  D. Hayes,et al.  Oligosaccharide differences in the DF3 sialomucin antigen from normal human milk and the BT-20 human breast carcinoma cell line. , 1989, Cancer communications.

[36]  J. Taylor‐Papadimitriou,et al.  Development and characterization of breast cancer reactive monoclonal antibodies directed to the core protein of the human milk mucin. , 1987, Cancer research.

[37]  T. Decker,et al.  Cell-associated tumor necrosis factor (TNF) as a killing mechanism of activated cytotoxic macrophages. , 1987, Journal of immunology.

[38]  J. Taylor‐Papadimitriou,et al.  Detection of the tumour‐associated antigens recognized by the monoclonal antibodies hmfg‐1 and 2 in serum from patients with breast cancer , 1984, International journal of cancer.

[39]  J. Taylor‐Papadimitriou,et al.  Complexity of expression of antigenic determinants, recognized by monoclonal antibodies HMFG-1 and HMFG-2, in normal and malignant human mammary epithelial cells. , 1983, Journal of immunology.